Alzamend Neuro Statistics Share Statistics Alzamend Neuro has 3.14M
shares outstanding. The number of shares has increased by 290.29%
in one year.
Shares Outstanding 3.14M Shares Change (YoY) 290.29% Shares Change (QoQ) 292.02% Owned by Institutions (%) 6.35% Shares Floating 3.12M Failed to Deliver (FTD) Shares 1,447 FTD / Avg. Volume 0.98%
Short Selling Information The latest short interest is 137.41K, so 4.38% of the outstanding
shares have been sold short.
Short Interest 137.41K Short % of Shares Out 4.38% Short % of Float 6.31% Short Ratio (days to cover) 2.15
Valuation Ratios The PE ratio is -0.59 and the forward
PE ratio is -0.47.
Alzamend Neuro's PEG ratio is
0.03.
PE Ratio -0.59 Forward PE -0.47 PS Ratio 0 Forward PS n/a PB Ratio 0 P/FCF Ratio -0.39 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Alzamend Neuro.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position Current Ratio 0 Quick Ratio 0 Debt / Equity 0 Debt / EBITDA -0.07 Debt / FCF -0.04 Interest Coverage -249.42
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.13M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -83.16% in the
last 52 weeks. The beta is -0.3, so Alzamend Neuro's
price volatility has been lower than the market average.
Beta -0.3 52-Week Price Change -83.16% 50-Day Moving Average 2.42 200-Day Moving Average 5.79 Relative Strength Index (RSI) 53.07 Average Volume (20 Days) 148,194
Income Statement
Revenue n/a Gross Profit -50.74K Operating Income -4.5M Net Income -4.51M EBITDA -4.45M EBIT -4.5M Earnings Per Share (EPS) -11.32
Full Income Statement Balance Sheet The company has 376.05K in cash and 300.71K in
debt, giving a net cash position of 75.33K.
Cash & Cash Equivalents 376.05K Total Debt 300.71K Net Cash 75.33K Retained Earnings -54.02M Total Assets 6.33M Working Capital 4.95M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -6.57M
and capital expenditures -300K, giving a free cash flow of -6.87M.
Operating Cash Flow -6.57M Capital Expenditures -300K Free Cash Flow -6.87M FCF Per Share -15.24
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ALZN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ALZN is $42,
which is 1600.4% higher than the current price. The consensus rating is "Buy".
Price Target $42 Price Target Difference 1600.4% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 12, 2025. It was a
backward
split with a ratio of 1:9.
Last Split Date May 12, 2025 Split Type backward Split Ratio 1:9
Scores Altman Z-Score -11.25 Piotroski F-Score 1
